News

This month’s newsletter is about the latest developments in Greater China in the IT security industry and our relation to this market. Read our newsletter here: newsletter-november-2016

This month’s newsletter is about Mobile Payment, its various technologies and methods and how we can help you before and during the certification of your Mobile Payment product. Read our Newsletter here: newsletter-september-2016

On the 27th and 28th of July, 2016, Brightsight held a PCI PTS seminar in China. This was the fourth consecutive seminar Brightsight organized in China to share the latest updates and changes to PCI PTS certification and evaluation requirements. This time, the seminar was held in the beautiful city ...

Delft, July 27th: Today Brightsight B.V. announces the retirement of one of the company’s CEOs, Jan Pieters, who has decided to retire effective August 1, 2016. Jan’s retirement will bring to a close a remarkable career of nearly 30 years of continuous service to Brightsight. “Jan started working in...

Delft, 25^th of July 2016: Brightsight is proud to announce that the first CSEC-C approval, based on a Brightsight report, was issued on the 13^th of July 2016. CSEC-C stands for “Common Security Evaluation & Certification” and is a collaboration between the UK Cards Association and the Assoc...

Sign up now for the fourth PCI Chinese Seminar! On the 27th and 28th the Chinese Seminar is held in Hangzhou, China. The main subject of the seminar will be the difference between PCI4.1 and PCI5.

The sub-topics are:

At Brightsight, Research and Development (R&D) is an important part of our daily work. We have a small team working on R&D full time, however everyone within Brightsight is encouraged to work on R&D, next to their usual pursuits. Innovation serves two purposes, it keeps the work fun and ...

Trustworthiness of medical devices comes with the assurance that the security requirements are clear and the security measures are adequate and correctly implemented. A typical security aspect that is at stake for medical devices is that the approved functional features of the product remain trustwo...

In this issue of Brightsight;’s newsletter we cover the following topics: